Thermo Fisher Scientific Inc. (LON: 0R0H)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 178.45B |
| Revenue (ttm) | 31.62B |
| Net Income (ttm) | 4.58B |
| Shares Out | n/a |
| EPS (ttm) | 11.90 |
| PE Ratio | 38.98 |
| Forward PE | n/a |
| Dividend | 1.22 (0.21%) |
| Ex-Dividend Date | Dec 13, 2024 |
| Volume | 1,378 |
| Average Volume | 1,278 |
| Open | 574.99 |
| Previous Close | 573.94 |
| Day's Range | 570.68 - 579.36 |
| 52-Week Range | 416.66 - 603.14 |
| Beta | 0.79 |
| RSI | 72.98 |
| Earnings Date | Jan 29, 2025 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno... [Read more]
Financial Performance
In 2023, Thermo Fisher Scientific's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.
Financial numbers in USD Financial StatementsNews
Thermo Fisher Scientific Unusual Options Activity For January 21
Financial giants have made a conspicuous bullish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE: TMO) revealed 11 unusual trades. Delving into th...
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 15 years by 6.03% on an annualized basis producing an average annual return of 17.98%. Currently, Thermo Fisher Scientif...
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo Fisher S...
Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Inc. (TMO) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly
The Investment Committee give you their top stocks to watch for the second half.
Unlocking Intrinsic Value: Analysis of Thermo Fisher Scientific Inc
Unlocking Intrinsic Value: Analysis of Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc (TMO) Partners with UK Biobank for Groundbreaking Proteomics Study
Thermo Fisher Scientific Inc (TMO) Partners with UK Biobank for Groundbreaking Proteomics Study
Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteome Study
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Oli...
The Art of Valuation: Discovering Thermo Fisher Scientific Inc's Intrinsic Value
The Art of Valuation: Discovering Thermo Fisher Scientific Inc's Intrinsic Value
Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full ye...
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 20 years by 7.25% on an annualized basis producing an average annual return of 15.55%. Currently, Thermo Fisher Scientif...
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Scotiaban...
TMO has been a fabulous performer over the last decade, says Jim Cramer
'Ma Money' host Jim Cramer talks how to play Thermo Fisher.
Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific
LAKEWOOD, N.J.--(BUSINESS WIRE)--Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and medic...
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 10 years by 3.93% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientif...
Thermo Fisher: The Cycle Has Already Turned Around
Thermo Fisher stock is a buy with signs of recovery and potential growth, backed by positive sales and margins. Read an analysis of TMO stock here.
Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc
Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc
Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic
Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with growth drivers in 2025 and beyond.
Thermo Fisher: M&A And Innovation To Drive Sales Growth
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued success with strong ROEs.
Thermo Fisher Scientific Inc (TMO) Completes $1 Billion Share Repurchase
Thermo Fisher Scientific Inc (TMO) Completes $1 Billion Share Repurchase
Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Deta...
Thermo Fisher Scientific completes $1B share repurchase
Thermo Fisher Scientific completes $1B share repurchase, with $3B still available for buybacks.
Thermo Fisher Scientific Completes $1B Share Repurchase
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares)...